A pilot study of abrupt verse gradual smoking cessation in combination with electronic nicotine devices for smokers receiving alcohol and other drug treatment.

Eliza Skelton, Maryanne Robinson, Alistair Lum, Adrian Dunlop, Amanda L. Baker, Coral Gartner, Ron Borland, Matthew Clapham, Billie Bonevski

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

People receiving alcohol and other drug treatment have high tobacco smoking rates and low quit rates. Vaporized nicotine products may be a potential quit smoking strategy for persons receiving drug and alcohol treatment. There are two identified methods for quitting smoking, the first is gradual cessation, which involves reducing the number of cigarettes over a set period of time before complete abstinence, while the second, abrupt, involves setting a quit date and stopping on that date. The feasibility of using a pharmacological strategy, such as an VNP in conjunction with a cessation strategy in combination, is yet to be examined...
Original languageEnglish
Article numberPP25
Pages (from-to)37-38
Number of pages2
JournalAsia-Pacific Journal of Clinical Oncology
Volume16
Issue numberS6
DOIs
Publication statusPublished - Nov 2020
Externally publishedYes
Event2020 Hunter Cancer Research Symposium - Newcastle City Hall, Newcastle, Australia
Duration: 6 Nov 20206 Nov 2020

Keywords

  • smoking cessation
  • electronic nicotine devices
  • Vaporized nicotine products

Fingerprint

Dive into the research topics of 'A pilot study of abrupt verse gradual smoking cessation in combination with electronic nicotine devices for smokers receiving alcohol and other drug treatment.'. Together they form a unique fingerprint.

Cite this